WASHINGTON, June 21, 2016 /PRNewswire-USNewswire/ -- The new PwC Health Research Institute (HRI) annual report ("Medical
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the new report:
"This report underscores how PBMs are driving competition and in turn reducing costs for consumers, employers, government programs, and unions. Policymakers should embrace greater use of proven PBM tools and reject drugmaker and drugstore lobby mandates that would increase prescription drug costs."
PBMs are projected to save employers, unions, government programs, and consumers $654 billion up to 30 percent on drug benefit costs over the next decade. Learn how PBMs reduce prescription drug costs and improve convenience and safety for consumers, employers, unions, and government programs at That's What PBMs Do.
PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pcma-on-new-pwc-report-pbms-driving-competition-to-reduce-drug-costs-300287957.html
SOURCE Pharmaceutical Care Management Association
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All